|
[1] Faget J, Peters S, Quantin X, et al. Neutrophils in the era of immune checkpoint blockade[J]. J Immunother Cancer, 2021, 9(7): e002242. [2] Ma Y, Yabluchanskiy A, Lindsey M L. Neutrophil roles in left ventricular remodeling following myocardial infarction[J]. Fibrogenesis Tissue Repair, 2013, 6(1): 11. [3] Amulic B, Cazalet C, Hayes G L, et al. Neutrophil function: from mechanisms to disease[J]. Annu Rev Immunol, 2012, 30: 459-489. [4] Cowland J B, Borregaard N. Granulopoiesis and granules of human neutrophils[J]. Immunol Rev, 2016, 273(1): 11-28. [5] Ballesteros I, Hidalgo A. The neutrophil collective[J]. Cell, 2025, 188(25): 7019-7035. [6]Rizo-Téllez S A, Sekheri M, Filep J G. Myeloperoxidase: regulation of neutrophil function and target for therapy[J]. Antioxidants, 2022, 11(11): 2302. [7] Lin W, Chen H, Chen X, et al. The roles of neutrophil-derived myeloperoxidase (MPO) in diseases: the new progress[J]. Antioxidants, 2024, 13(1): 132. [8] Coussens L M, Werb Z. Inflammation and cancer[J]. Nature, 2002, 420(6917): 860-867. [9] Jannesar K, Soraya H. MPO and its role in cancer, cardiovascular and neurological disorders: an update[J]. Biochem Biophys Res Commun, 2025, 755: 151578. [10] Yazdani H O, Roy E, Comerci A J, et al. Neutrophil extracellular traps drive mitochondrial homeostasis in tumors to augment growth[J]. Cancer Res, 2019, 79(21): 5626-5639. [11] Karimi E, Yu M W, Maritan S M, et al. Single-cell spatial immune landscapes of primary and metastatic brain tumours[J]. Nature, 2023, 614(7948): 555-563. [12] Huang H, Zhang H, Onuma A E, et al. Neutrophil elastase and neutrophil extracellular traps in the tumor microenvironment[J]. Adv Exp Med Biol, 2020, 1263: 13-23. [13] Houghton A M, Rzymkiewicz D M, Ji H, et al. Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth[J]. Nat Med, 2010, 16(2): 219-223. [14] Castaño M, Tomás-Pérez S, González-Cantó E, et al. Neutrophil extracellular traps and cancer: trapping our attention with their involvement in ovarian cancer[J]. Int J Mol Sci, 2023, 24(6): 5995. [15] Piotrowski I, Kulcenty K, Suchorska W. Interplay between inflammation and cancer[J]. Rep Pract Oncol Radiother, 2020, 25(3): 422-427. [16] 魏秀珍, 张政杰, 谭勇, 等. 胃癌转移相关因子的研究进展[J]. 国际老年医学杂志, 2024, 45(2): 234-237. Wei X Z, Zhang Z J, Tan Y, et al. Research progress of metastasis related factors in gastric cancer[J]. Int J Geriatr, 2024, 45(2): 234-237. [17] Jia W, Luo Q, Wu J, et al. Neutrophil elastase as a potential biomarker related to the prognosis of gastric cancer and immune cell infiltration in the tumor immune microenvironment[J]. Sci Rep, 2023, 13(1): 13447. [18] Jia W, Mao Y, Luo Q, et al. Targeting neutrophil elastase is a promising direction for future cancer treatment[J]. Discov Oncol, 2024, 15(1): 167. [19] Zeng W, Song Y, Wang R, et al. Neutrophil elastase: from mechanisms to therapeutic potential[J]. J Pharm Anal, 2023, 13(4): 355-366. [20] Albrengues J, Shields M A, Ng D, et al. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice[J]. Science, 2018, 361(6409): eaao4227. [21] Kai F, Drain A P, Weaver V M. The extracellular matrix modulates the metastatic journey[J]. Dev Cell, 2019, 49(3): 332-346. [22] Zeng Y, Gao M, Lin D, et al. Prognostic and immunological roles of MMP-9 in pan-cancer[J]. Biomed Res Int, 2022, 2022: 2592962. [23] Cai N, Cheng K, Ma Y, et al. Targeting MMP9 in CTNNB1 mutant hepatocellular carcinoma restores CD8+ T cell-mediated antitumour immunity and improves anti-PD-1 efficacy[J]. Gut, 2024, 73(6): 985-999. [24] Shoari A, Ashja Ardalan A, Dimesa A M, et al. Targeting invasion: the role of MMP-2 and MMP-9 inhibition in colorectal cancer therapy[J]. Biomolecules, 2024, 15(1): 35. [25] Juric V, O'sullivan C, Stefanutti E, et al. MMP-9 inhibition promotes anti-tumor immunity through disruption of biochemical and physical barriers to T-cell trafficking to tumors[J]. PLoS One, 2018, 13(11): e0207255. [26] Huang G Z, Wu Q Q, Zheng Z N, et al. Bioinformatics analyses indicate that cathepsin G (CTSG) is a potential immune-related biomarker in oral squamous cell carcinoma (OSCC)[J]. Onco Targets Ther, 2021, 14: 1275-1289. [27] Dai Q, Yao X, Zhang Y, et al. CTSG is a prognostic marker involved in immune infiltration and inhibits tumor progression though the MAPK signaling pathway in non-small cell lung cancer[J]. J Cancer Res Clin Oncol, 2024, 151(1): 21. [28] Lin M, Jackson P, Tester A M, et al. Matrix metalloproteinase-8 facilitates neutrophil migration through the corneal stromal matrix by collagen degradation and production of the chemotactic peptide Pro-Gly-Pro[J]. Am J Pathol, 2008, 173(1): 144-153. [29] Wu Y, Liu H, Sun Z, et al. The adhesion-GPCR ADGRF5 fuels breast cancer progression by suppressing the MMP8-mediated antitumorigenic effects[J]. Cell Death Dis, 2024, 15(6): 455. [30] Gutiérrez-Fernández A, Fueyo A, Folgueras A R, et al. Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion[J]. Cancer Res, 2008, 68(8): 2755-2763. [31] Juurikka K, Dufour A, Pehkonen K, et al. MMP8 increases tongue carcinoma cell-cell adhesion and diminishes migration via cleavage of anti-adhesive FXYD5[J]. Oncogenesis, 2021, 10(5): 44. [32] Juurikka K, Butler G S, Salo T, et al. The role of MMP8 in cancer: a systematic review[J]. Int J Mol Sci, 2019, 20(18): 4506. [33] Jiang Y, Li X, Yang Y, et al. LncRNA HOXC-AS1 sponges miR-99a-3p and upregulates MMP8, ultimately promoting gastric cancer[J]. Cancers, 2022, 14(14): 3534.
|